WHO IS WATCHMAN FOR?
NON VALVULAR AFIB PATIENTS
WHAT TYPE OF IMAGING WAS USED IN THIS TRIAL?
CT SCANS
IS WATCHMAN MRI FRIENDLY?
WATCHMAN IS MR CONDITIONAL
WHAT TRIAL LEAD TO THE FDA APPROVAL OF THE WATCHMAN FLX?
PINNACLE FLX
WHAT IS THE MOST POPULAR DOAC?
ELIQUIS
WHAT DOES DAPT STAND FOR?
DUAL ANTI PLATELET THERAPY
HOW MANY PATIENTS WERE INCLUDED IN THE TRIAL?
3000
WHAT DOES THE "PASS" CRITERIA STAND FOR BEFORE RELEASING A WATCHMAN FLX DEVICE?
POSITION, ANCHOR, SIZE, AND SEAL
WHICH LANDMARK WATCHMAN TRIAL FIRST DEMONSTRATED NON INFERIORITY TO WARFARIN FOR STROKE PREVENTION IN NVAF PATIENTS?
PROTECT AF
Which DOAC(s) showed an overall lower incidence of major bleeding versus warfarin?
ELIQUIS
THE WATCHMAN DEVICE IS COMMONLY DESCRIBED WITH THESE THREE WORDS.
PROVEN, SAFE, AND EFFECTIVE
WHAT IS THE HAS BLED AND CHADSVASC SCORES FOR THE TRIAL?
HAS BLED: 1.3
CHADSVASC: 3.5
WHAT SIZE LEAK IS ACCEPTABLE, PER THE IFU, AT THE 45 DAY FOLLOW UP?
LESS THAN OR EQUAL TO 5MM
WHICH TWO CLINICAL TRIALS HAD THE SAME CHADSVASC SCORE?
OPTION AND CHAMPION (3.5)
WHAT DOES INR STAND FOR?
INTERNATIONAL NORMALIZED RATIO
WHAT YEAR DID WATCHMAN RECEIVE FDA APPROVAL?
2015
WHAT WAS THE PRIMARY SAFETY ENDPOINT?
STATISTICAL SUPERIORITY TO NOACS FOR THE OCCURRENCE OF ISTH NON PROCEDURAL MAJOR BLEEDING AND MODIFIED CLINICALLY RELEVANT NON MAJOR BLEEDING
CARDIOVERSION WITHIN HOW MANY DAYS OF IMPLANT CARRIES POTENTIAL EMBOLIZATION RISK?
WITHIN 30 DAYS.
WHAT REAL WORLD REGISTRY EVALUATES OUTCOMES FROM COMMERICAL WATCHMAN IMPLANTS IN THE UNITED STATES?
NCDR LAAO REGISTRY
NATIONAL CARDIOVASCULAR DATA REGISTRY LEFT ATRIAL APPENDAGE OCCLUSION
ACCORDING TO THE 2025 FDA ADVISORY, USE OF CONSCIOUS SEDATION OF POSITIVE PRESSURE VENTILATION INCREASED RISK OF WHAT COMPLICATION?
AIR EMBOLISM
WHAT ARE THE FIVE STEPS OF THE WATCHMAN PROCEDURE?
1. ACCESS
2. CROSS
3. DEPLOY
4. HEAL
5. PROTECT
WHAT IS THE DRT (DEVICE RELATED THROMBUS) PERCENT AT FOUR MONTHS FOR WATCHMAN?
4.8%
NAME THE SIX SIZES OF THE WATCHMAN DEVICE.
20 MM, 24 MM, 27MM, 31 MM, 35 MM AND 40 MM
WHAT PERCENTAGE OF PATIENTS ACHIEVED COMPLETE SEAL (0 MM LEAK) AT 45 DAYS IN SURPASS PRO?
88%
WHAT IS THE TYPICAL INR GOAL RANGE?
2-3